Blog Archive

Wednesday, February 3, 2021

Oragenics news 02/02/2021

 

*Oragenics Announces Spike Protein Cov-2 S-2P Created By The NIH And Licensed By The Company Demonstrates Protective
 Immunity In Immunized Mice Challenged With Mouse-adapted Sars-CoV-2 Virus(Benzinga)

No comments:

Post a Comment

SNGX

 The future outlook for Soligenix (SNGX) stock is mixed with both potential upside and high risks. Here's an overview of what analysts ...

Labels